Citadel Advisors »

Omega Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Omega Therapeutics (OMGAQ) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Omega Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Omega Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Omega Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $23k 30k 0.75
2024-09-30 $16k 13k 1.22
2024-06-30 $2.2M 1.1M 2.07
2024-03-31 $198k 54k 3.65
2023-09-30 $99k 46k 2.15
2023-06-30 $96k 17k 5.60
2023-03-31 $143k 24k 6.03
2022-12-31 $220k 39k 5.71
2022-06-30 $142k 37k 3.82

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Omega Therapeutics

Huntington National Bank

View all funds holding Omega Therapeutics